Thomas J. Grabowski

<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Thomas J. Grabowski</th>
</tr>
<tr> [@learning2021]
<td class="infobox-image" colspan="2"> [@quantitative2018]
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of Washington</td>
</tr>
<tr>
<td class="label">Country</td>
<td>United States</td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Default Mode Network, Connectivity-based Parcellation, Dynamic Connectivity</td>
</tr>
</table>

Thomas J. Grabowski

Overview

Thomas J. Grabowski plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Thomas J. Grabowski is a prominent neuroscientist and neurologist at the University of Washington, where he leads research on functional brain connectivity, neuroimaging methodology, and the application of machine learning to understand neurodegenerative diseases. His work has significantly advanced our understanding of how brain networks change in Alzheimer's disease and Parkinson's disease, contributing to improved diagnostic approaches and biomarker development.

Research Focus

<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Thomas J. Grabowski</th>
</tr>
<tr> [@learning2021]
<td class="infobox-image" colspan="2"> [@quantitative2018]
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of Washington</td>
</tr>
<tr>
<td class="label">Country</td>
<td>United States</td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Default Mode Network, Connectivity-based Parcellation, Dynamic Connectivity</td>
</tr>
</table>

Thomas J. Grabowski

Overview

Thomas J. Grabowski plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Thomas J. Grabowski is a prominent neuroscientist and neurologist at the University of Washington, where he leads research on functional brain connectivity, neuroimaging methodology, and the application of machine learning to understand neurodegenerative diseases. His work has significantly advanced our understanding of how brain networks change in Alzheimer's disease and Parkinson's disease, contributing to improved diagnostic approaches and biomarker development.

Research Focus

Disease Areas

• [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease-disease), [Mild Cognitive Impairment](/diseases/mild-cognitive-impairment)

Mechanisms of Interest

• Default Mode Network, Connectivity-based Parcellation, Dynamic Connectivity
• Functional Connectivity Analysis
• Machine Learning in Neuroimaging
• Brain Network Dynamics

Major Research Contributions

Default Mode Network in Neurodegeneration

Dr. Grabowski's research has been instrumental in understanding how the Default Mode Network (DMN) is affected in neurodegenerative diseases. His work has demonstrated alterations in functional connectivity within DMN regions that correlate with cognitive decline in both Alzheimer's disease and Parkinson's disease. These findings have important implications for early detection and monitoring of disease progression.

Key Findings

• Network optimization approaches for detecting cognitive decline using DMN connectivity patterns
• Altered DMN-executive attention network interactions in Parkinson's disease
• Dynamic connectivity changes at rest predict attention task performance
• Integration of multimodal neuroimaging data for improved biomarker sensitivity

Connectivity-Based Cortical Parcellation

A significant portion of Dr. Grabowski's work has focused on developing advanced methods for partitioning the cerebral [cortex](/brain-regions/cortex) into functionally meaningful regions. His research on connectivity-based parcellation using diffusion MRI has provided new tools for studying brain organization in both healthy aging and disease states.

Quantitative Cerebrovascular Pathology

His community-based studies have characterized cerebrovascular pathology in older adults, examining the relationship between vascular changes and cognitive decline. This research highlights the importance of vascular contributions to neurodegenerative processes and informs prevention strategies.

Methodological Innovations

Machine Learning Applications

Dr. Grabowski has pioneered the application of machine learning techniques to neuroimaging data, including:

• Graph neural networks for cortical parcellation
• Support vector machines for disease classification
• Deep learning approaches for analyzing longitudinal imaging data

Cloud Computing in Neuroimaging

His work on running neuroimaging applications on cloud platforms (Amazon Web Services) has democratized access to computationally intensive analyses, enabling researchers without dedicated HPC resources to conduct sophisticated neuroimaging studies.

Collaborations

Dr. Grabowski has collaborated extensively with researchers across multiple institutions, contributing to:

• Alzheimer's Disease Neuroimaging Initiative (ADNI)
• Parkinson's Progression Markers Initiative (PPMI)
• National Institute on Aging funded studies
• International neuroimaging consortia

Training and Mentorship

As a senior investigator at University of Washington, Dr. Grabowski has mentored numerous graduate students and postdoctoral fellows in neuroimaging techniques, statistical analysis, and scientific writing. His lab has produced researchers who have gone on to establish independent careers in academia and industry.

Selected Publications

See Also

• [University of Washington](/university-of-washington)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroimaging](/mechanisms/neuroimaging-methodology)
• [PET Imaging](/mechanisms/pet-imaging)
• [Default Mode Network](/mechanisms/default-mode-network)
• [Functional Connectivity](/mechanisms/functional-connectivity)

External Links

• [PubMed Search](https://pubmed.ncbi.nlm.nih.gov/?term=Thomas+J.+Grabowski)

Overview

Thomas J. Grabowski plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Thomas J. Grabowski has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Recent Research (2024-2026)

• Connell E et al. [A novel Mediterranean diet-inspired supplement reduces hippocampal amyloid deposits and microglial activation through the modulation of the microbiota gut-brain axis in 5xFAD mice](https://doi.org/10.1080/19490976.2026.2614030). Gut microbes. 2026;:.
• Lv X et al. [Blautia coccoides-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signaling](https://doi.org/10.1080/19490976.2025.2605768). Gut microbes. 2026;:.
• Wang RM et al. [lncRNAs: key player in Aβ deposition](https://doi.org/10.1080/15476286.2026.2639017). RNA biology. 2026;:.
• Imaizumi LFI et al. [Cognitive load alters cortical dynamics during gait in Parkinson's disease but not in neurologically healthy individuals](https://doi.org/10.1007/s11571-026-10424-4). Cognitive neurodynamics. 2026;:.

Research Contributions

References